According to Market Research Future (MRFR), the global animal model market is poised to create a valuation of USD 3,632.48 million by 2027, growing at approximately 7.8% CAGR throughout the forecast period (2020 – 2027). Increasing preference for animal models as a base material in various types of research activities is a key growth driver. Besides, rising research activities in contract research organizations (CRO) for drug discoveries boost the growth of the market.
Animal models are critical for biomedical research in the drug discovery ecosystem and other tests used in the production and quality control process in food and personal care products industries. These models enable foreign tissue to interact with them and provide the foundation for specific genetic and tissue modifications for greater precision. Better replication of the human body is a driving force in many revolutionary medical advances, including immuno-oncology and personalized medicine.
Additionally, recent COVID 19 pandemic has created the demand for model animals with human versions of a protein called the ace2 receptor. This molecule is the hook that sars-cov-2, the virus which causes COVID-19. Resultantly, the market is estimated to garner massive traction in the years to come. On the other hand, stringent regulation on the use of animals in research and lack of skill of recapitulating the human biosystem in an animal model are major factors expected to impede the growth of the market.
Animal Model Market – Regional Analysis
North America dominates the global animal model market. The largest market share attributes to the growing preclinical activities in pharmaceutical and biotech companies during drug development. Besides, factors such as the increasing use of animal models by CROs and focus on personalized medicine creates the demand for animal models in this region. Moreover, favorable reimbursement scenario and rising RD investments and activities in pharmaceutical and biotechnology substantiate the regional market growth.
Europe stands second in the global animal model market. The market growth attributes to increasing cancer research and the presence of a huge number of research laboratories and pharma companies in this region. Moreover, growing innovation in the healthcare industry and increasing focus on drug discoveries and therapeutics foster regional market growth. Improving economy in the region is also an important driver for the market growth, increasing per capita healthcare expenses.
The Asia Pacific animal model market is growing rapidly. Factors such as the increasing research on biomedical and regenerative medicine in the region, drive the growth of the market. Besides, rising medical research in countries like China, Japan, India, and others increases market growth. Moreover, the fastest growing healthcare sector, coupled with the burgeoning pharmaceutical and biotechnology industries in the region, provide impetus to the market growth.
Players leading the animal model market include GenOway S.A. (France), Janvier Labs (France), Envigo (US), Taconic Laboratories (UK), Charles River Laboratories (UK), Transgenic, Inc. (Japan), Horizon Discovery (England), SAGE Labs (US), Harbor Antibodies BV (Subsidiary – Harbor BioMed – US), and Crown Bioscience Inc. (US), among others.